tradingkey.logo

Bio Rad Laboratories Inc

BIO
301.500USD
+1.960+0.65%
終値 02/06, 16:00ET15分遅れの株価
8.13B時価総額
損失額直近12ヶ月PER

Bio Rad Laboratories Inc

301.500
+1.960+0.65%

詳細情報 Bio Rad Laboratories Inc 企業名

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Bio Rad Laboratories Incの企業情報

企業コードBIO
会社名Bio Rad Laboratories Inc
上場日Mar 17, 1980
最高経営責任者「CEO」Schwartz (Norman D)
従業員数7700
証券種類Ordinary Share
決算期末Mar 17
本社所在地1000 Alfred Nobel Dr
都市HERCULES
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号94547
電話番号15107247000
ウェブサイトhttps://www.bio-rad.com/
企業コードBIO
上場日Mar 17, 1980
最高経営責任者「CEO」Schwartz (Norman D)

Bio Rad Laboratories Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.39M
+951364.00%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+1071.00%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+709.00%
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+739.00%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+308.00%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
612.00
+493.00%
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
308.00
+308.00%
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
308.00
+308.00%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. Edward Chung
Mr. Edward Chung
Vice President - Investor Relations
Vice President - Investor Relations
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.39M
+951364.00%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+1071.00%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+709.00%
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+739.00%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+308.00%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
612.00
+493.00%

収益内訳

通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
United States
270.00M
41.35%
EMEA
222.20M
34.03%
APAC
121.00M
18.53%
Other
39.80M
6.09%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Mon, Feb 2
更新時刻: Mon, Feb 2
株主統計
種類
株主統計
株主統計
比率
First Eagle Investment Management, L.L.C.
11.50%
Alice N. Schwartz Revocable Trust
8.13%
The Vanguard Group, Inc.
8.08%
BlackRock Institutional Trust Company, N.A.
6.77%
Schwartz (Norman D)
6.36%
他の
59.15%
株主統計
株主統計
比率
First Eagle Investment Management, L.L.C.
11.50%
Alice N. Schwartz Revocable Trust
8.13%
The Vanguard Group, Inc.
8.08%
BlackRock Institutional Trust Company, N.A.
6.77%
Schwartz (Norman D)
6.36%
他の
59.15%
種類
株主統計
比率
Investment Advisor/Hedge Fund
45.17%
Investment Advisor
40.02%
Individual Investor
8.25%
Corporation
8.13%
Hedge Fund
5.13%
Research Firm
1.16%
Pension Fund
1.12%
Bank and Trust
0.96%
Sovereign Wealth Fund
0.63%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
1040
20.58M
101.60%
-3.97K
2025Q3
1095
20.58M
103.17%
+603.60K
2025Q2
1114
19.81M
108.02%
-855.27K
2025Q1
1146
19.96M
99.31%
-2.83M
2024Q4
1140
19.39M
101.48%
-657.49K
2024Q3
1121
20.03M
101.42%
-386.71K
2024Q2
1139
20.32M
91.46%
+1.29M
2024Q1
1154
19.07M
91.02%
-2.25M
2023Q4
1187
19.09M
89.28%
-259.69K
2023Q3
1170
19.31M
88.28%
-552.69K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
First Eagle Investment Management, L.L.C.
2.52M
11.5%
+3.01K
+0.12%
Sep 30, 2025
Alice N. Schwartz Revocable Trust
1.78M
8.13%
--
--
Sep 25, 2025
The Vanguard Group, Inc.
1.79M
8.17%
-53.01K
-2.88%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.48M
6.77%
-61.47K
-3.98%
Sep 30, 2025
Schwartz (Norman D)
1.39M
6.36%
+951.36K
+214.86%
Sep 25, 2025
Dimensional Fund Advisors, L.P.
1.06M
4.85%
+63.37K
+6.34%
Sep 30, 2025
Veritas Asset Management LLP
844.04K
3.85%
-19.10K
-2.21%
Sep 30, 2025
Ariel Investments, LLC
809.48K
3.7%
-9.14K
-1.12%
Sep 30, 2025
EARNEST Partners, LLC
609.28K
2.78%
+3.40K
+0.56%
Sep 30, 2025
State Street Investment Management (US)
571.60K
2.61%
-12.77K
-2.18%
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Parnassus Value Select ETF
3.94%
First Trust Indxx Medical Devices ETF
2.15%
ROBO Global Healthcare Technology & Innovation ETF
1.61%
Schwab Ariel Opportunities ETF
1.6%
First Trust Health Care Alphadex Fund
1.49%
FPA Global Equity ETF
1.38%
First Eagle Global Equity ETF
1.21%
iShares Health Innovation Active ETF
1.17%
Pacer US Export Leaders ETF
1.03%
Harbor Health Care ETF
0.82%
詳細を見る
Parnassus Value Select ETF
比率3.94%
First Trust Indxx Medical Devices ETF
比率2.15%
ROBO Global Healthcare Technology & Innovation ETF
比率1.61%
Schwab Ariel Opportunities ETF
比率1.6%
First Trust Health Care Alphadex Fund
比率1.49%
FPA Global Equity ETF
比率1.38%
First Eagle Global Equity ETF
比率1.21%
iShares Health Innovation Active ETF
比率1.17%
Pacer US Export Leaders ETF
比率1.03%
Harbor Health Care ETF
比率0.82%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
KeyAI